Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Lithocholic Acid Kills Cancer, Spares Healthy Cells

By BiotechDaily International staff writers
Posted on 19 Jan 2012
Lithocholic acid (LCA), naturally generated in the liver during digestion, has been seriously underestimated because new research has revealed that LCA can kill several kinds of cancer cells, such as those found in breast cancer and various brain tumors.

The researchers, led by Concordia University (Austin, TX, USA), included scientists from McGill University (Montreal, Canada) and the Jewish General Hospital’s Lady Davis Institute (Montreal, Canada), as well as the University of Saskatchewan (Saskatoon, Canada). The study’s findings were published October 2011 in the journal Oncotarget.

Earlier research from the same investigators demonstrated LCA also extends the lifespan of aging yeast. This time, the team found LCA to be very selective in killing cancer cells while leaving normal cells unscathed. This could translate into a great improvement over the indiscriminant all-cell damaging drugs used in chemotherapy.

“LCA doesn’t just kill individual cancer cells. It could also prevent the entire tumor from growing,” stated senior author Vladimir Titorenko, a professor in the department of biology and Concordia University research chair in genomics, cell biology, and aging.

Moreover, LCA prevents tumors from releasing substances that cause neighboring cancer cells to grow and proliferate. Prof. Titorenko noted that LCA is the only compound that targets cancer cells, which could translate into tumor-halting power. “This is important for preventing cancer cells from spreading to other parts of the body,” he said, noting that unlike other antiaging compounds, LCA blocks cancer cell growth yet lets normal cells continue to grow.

The next phase for the research team will be to test LCA’s effect on different cancers in mice models. Prof. Titorenko expects that LCA will also kill cancer cells in the research and lead to human clinical trials. “Our study found that LCA kills not only tumors [neuroblastomas], but also human breast cancer cells,” said Prof. Titorenko. “This shows that it has a wide effect on different types of cancers.”

Prof. Titorenko emphasized that dissimilar to agent utilized in chemotherapy, LCA is a natural compound that is already present in humans. Studies have shown that LCA can be safely given to mice by adding it to their food. Therefore, scientists are looking into why LCA is so lethal for cancer cells. Prof. Titorenko conjectures that cancer cells have more sensors for LCA, which makes them more sensitive to the compound than normal cells.

LCA sensors transmit signals to mitochondria. It seems that when these signals are too strong, mitochondria self-destruct and take the cell along with them. Simply stated, Prof. Titorenko and his colleagues engaged in cancer cell disruption by targeting a weakness to LCA.

Related Links:
Concordia University
McGill University
Jewish General Hospital’s Lady Davis Institute



Channels

Genomics/Proteomics

view channel
Image: Transmission electron micrograph of norovirus particles in feces (Photo courtesy of Wikimedia Commons).

Norovirus Interacts with Gut Bacteria to Establish a Persistent Infection That Can Be Blocked by Interferon Lambda

A team of molecular microbiologists and virologists has found that norovirus requires an intimate interaction with certain gut bacteria to establish a persistent infection, and that the infective process... Read more

Drug Discovery

view channel

Curcumin Used to Treat Alzheimer’s Disease

Curcumin, a natural substance found in the spice turmeric, has been used by many Asian cultures for centuries. Now, new research suggests that a close chemical analog of curcumin has properties that may make it useful as a treatment for Alzheimer’s disease. “Curcumin has demonstrated ability to enter the brain, bind... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.